Serum neuron-specific enolase is correlated with clinical outcome of patients with non-germinal center B cell-like subtype of diffuse large B-cell lymphoma treated with rituximab-based immunochemotherapy
- 30 August 2011
- journal article
- Published by Springer Science and Business Media LLC in Medical Oncology
- Vol. 29 (3), 2153-2158
- https://doi.org/10.1007/s12032-011-0049-z
Abstract
The present study examines the clinical significance of serum neuron-specific enolase (NSE) in patients with non-germinal center B-cell type (non-GCB) of diffuse large B-cell lymphoma (DLBCL) that received rituximab chemotherapy. Serum NSE values were measured using electrochemiluminescence assay in 53 patients. About 54.7% of the DLBCL patients had positive expression of serum NSE (>15.20 ng/ml), which closely correlated with performance status, serum LDH level, B symptoms, IPI scores, and Ann-Arbor stages (P < 0.05). The mean serum NSE value in patients with non-GCB subtype of DLBCL was significantly higher than that of GCB subtype of DLBCL (P = 0.001), and among patients in non-GCB subtype group, there was significant difference in the 5-year OS rate between NSE-positive group and negative group (28.3% vs. 81.6%, P < 0.001). Furthermore, serum NSE level was found to be an independent prognostic factor in patients with non-GCB subtype. Serum NSE may be a novel marker of disease aggressiveness as well as a prognostic factor for non-GCB subtype of DLBCL in the era of rituximab.Keywords
This publication has 20 references indexed in Scilit:
- The expression of anamorsin in diffuse large B cell lymphoma: Possible prognostic biomarker for low IPI patientsLeukemia & Lymphoma, 2008
- Rituximab therapy in malignant lymphomaOncogene, 2007
- Evaluation of immunophenotype in diffuse large B-cell lymphoma and its impact on prognosisLaboratory Investigation, 2005
- Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarrayBlood, 2004
- Enhanced Expression of Neuron-specific Enolase (NSE) in Pyothorax-associated Lymphoma (PAL)Japanese Journal of Cancer Research, 2002
- Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slicesNeuropharmacology, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- Prospects for pirarubicinMedical and Pediatric Oncology, 1994
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1993
- NEURON-SPECIFIC ENOLASE IS PRODUCED BY NEUROENDOCRINE TUMOURSThe Lancet, 1981